Open
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Take a look at the link below. Linked are APRU’s 2nd Quarter 2018 Results versus APRU’s 2nd Quarter 2019 Results. (Page 11)
2018 2nd Quarter sales $280,800....Net Loss ($51,767)
2019 2nd Quarter sales $225,542....Net Loss ($898,455)
https://backend.otcmarkets.com/otcapi/company/financial-report/228554/content
Ask yourself this question. If business is really good as folks say, why did APRU’s sales drop so much versus 2018, and why are losses 17X larger in 2019?
Clearly APRU isn’t the growth company people believe. The actual numbers prove it’s not.
Doesn’t matter. Perhaps you should read up on it.
https://www.healthline.com/nutrition/fruit-juice-is-just-as-bad-as-soda
Doesn’t make sense to be marketing heavily in North Dakota because the population density is so low. Hardly anyone lives there. If APRU was really doing anything, why focus on North Dakota as a market with shipping costs? APRU management makes zero sense and company efforts are seriously misguided. No surprise sales are plummeting.
You like the product because Apple Rush drinks have a ton of sugar. The human brain loves sugar and salt. Just because you like a product doesn’t mean the company is a good stock to buy. No shortage of companies with a good product but fail for other factors. And no drink company is worth paying 60 or more X’s sales. Currently APRU is priced in the stratosphere, and when people place a price to sales multiple this high, something is going to give back a lot.
OTC Markets has Skull & Crossbone Warning up now. Caveat Emptor on CBIS (See Link).
https://www.otcmarkets.com/stock/CBIS/overview
Liquidity is drying up in APRU. Even as APRU’s price per share has been going lower and lower since mid July, average daily trading volumes are going lower and lower as well.
https://ih.advfn.com/stock-market/USOTC/apple-rush-co-inc-pn-APRU/historical/more-historical-data
Funny thing is HIPH had a 1 for 5000 reverse split back on July 12, 2017.
Now according to OTC Markets, HIPH reported 625,892,421 outstanding shares as of July 10, 2019.
So hypothetically, if you reversed out the 1 for 5000 reverse split, HIPH would have,
3,129,462,105,000 shares or LOL....3.1 TRILLION shares!!!!!
Even funnier is you can multiply this out farther because the company also had a 1 for 1000 reverse split on March 17, 2015 and had 1 for 1000 reverse split on February 21, 2014.
Now take the 3.1 trillion, reverse out these two 1 for 1000 splits and my calculator doesn’t have enough digits.
And all a reverse split is, is an accounting trick to lower the outstanding share count and raise the price per share. No values change.
Dilution Machine.
And considering all those shares sold, at the end of last Quarter HIPH was down to just $3473 in cash in the most recent Quarterly Report.
I had warned nonstop on CBIS. Sorry for your losses. If you’ve lost money, you paid for a learning experience. Don’t put money into financially dark companies that are managed by known fraudsters.
The problem is the bid/ask spread is more than 30% and trading volume has fallen off a cliff. With bid/ask spreads this wide, flippers couldn’t even play GRBX. There is virtually no demand for GRBX shares because GRBX management provides zero transparency.
Read this link below.
https://www.nbc29.com/story/40698405/biohemp-international-inc-otc-bkit-appoints-ryan-fishoff-as-lead-advisor-to-company-to-assist-with-cbd-distribution-consolidation-focus
So Ryan Fishoff, HIPH’s CEO hooks up as Special Advisor to ticker symbol BKIT on June 24, 2019.
Now take a look at BKIT’s 3 month stock chart, and what happened to those shares after Ryan Fishoff started there. Just amazing.
Click on HEMP’s 1 year chart. Notice how the stock ran up in late November 2018 in anticipation of the Farm Bill passing. Farm Bill gets signed into law on December 20, 2018....HEMP shares peak, and it’s been a steep downhill ride ever since. Can anyone say, Pump and Dump?
Why wouldn’t the price and terms of the tender offer not be public? Makes no sense. HMNY is not a private company. If the tender offer is legitimate, price/terms should be public info. This PR isn’t adding up.
Do you see an 8-K filing on this offer? Nope. SEC delinquent? Yes. OTC warnings up.
https://www.otcmarkets.com/stock/HMNY/disclosure
APRU is currently trading at roughly 75X sales.
One of the most successful companies in the world, Apple by comparison is trading at roughly 4X sales.
Why on earth would anyone believe that APRU deserves a price to sales multiple that is nearly 18X that of Apple? Makes zero sense.
APRU’s current valuation is in the clouds, and fundamentally it makes zero sense. Especially for a juice company with declining sales and rapidly accelerating losses.
Something is gonna give because APRU’s PPS again makes zero sense.
Sales at APRU have been dropping fast and net losses are quickly accelerating at APRU.
2nd Quarter 2018 sales were $280,800
2nd Quarter 2019 sales were $225,543
And Net Losses have accelerated extremely fast.
2nd Quarter 2018 Net Loss = ($51,767)
2nd Quarter 2019 Net Loss = ($898,455)
Net Losses have increased more than 1700%.
Think about this....in the latest 2nd Quarter, for every $1 in sales, APRU lost nearly $4 bucks.
GOHE has been diluting common shares at a fast pace.
On July 19, 2019 GOHE had a 1 for 100 reverse stock split. Figures I have used below account for the 1 for 100 split.
On June 30, 2018 GOHE reported 17,466,946 common shares outstanding (adjusted for split)
On June 30, 2019 GOHE reported 36,066,566 common shares outstanding
On July 19, 2019 GOHE reported 44,349,279 common shares outstanding
Indeed GOHE is diluting common shareholders at a very high rate.
I couldn’t possibly know that sorry.
Did you notice this alleged “news” of an unsolicited offer came without any price disclosure? IMO, without terms in this “news”, call me suspicious. Because an alleged unsolicited offer without terms of the offer is meaningless.
Know that NUGS “news” doesn’t add up.
NUGS stock performance.
1 week.......-10%
1 month......-36%
3 month......-57%
6 month......-75%
1 year.........-94%
When the SEC suspends HEMP, shareholders are screwed. Fraudsters are gonna get shut down and “investors” will lose all of their “investment”.
If the OTC Markets warning still isn’t enough for you, oh well.
https://www.otcmarkets.com/stock/HEMP/overview
OTC Warning on HMNY
Why does HMNY management hide company finances from the public? And why is management so delinquent in its financial reporting?
Legitimate public companies don’t hide their books.
https://www.otcmarkets.com/stock/HMNY/overview
Checkout today’s trades in DIRV. Notice any unusual trading activity here? LOL
https://ih.advfn.com/stock-market/USOTC/directview-holdings-inc-DIRV/trades
Trading volume in GRBX has virtually disappeared. You can get in but can’t get out without a big loss.
GOHE = Dilution Machine
GOHE’s 1 month stock chart tells the story.
SURG posted record Net Losses in the latest Quarter.
SURG lost $4,117,618 in the first 6 months of 2019.
Shareholders are gonna need to cover SURG’s rapidly growing cash burn rate.
Pull up SURG’s 1 year chart and you can see a classic head and shoulders formation setting new lows.
SURG doesn’t add up.
HEMP = Fake News Dilution Company
Net Losses at SURG are rapidly accelerating.
For the first 6 months of 2018 SURG had a profit of $25,883
For the first 6 months of 2019 SURG had a loss of ($4,117,618)
In 2019 thus far, SURG is averaging losses of $686,269 PER MONTH.
DIRV is stuck in a death spiral with trading volume dried up. Only $621 in trading volume all day and DIRV has nearly $25 million dollars of debts. Liquidity is gone.
Click HIPH’s 6 month stock chart. HIPH running out of equity capital fast.
HEMP = Share Selling Dilution Scam
More than 5 Billion common shares outstanding now and there are an unlimited number of new HEMP common shares. Want more? HEMP will print as many new shares as people want to buy. Unlimited supply.
If you understand supply and demand principals, you’ll know where this ticker is going.
HEMP has more than 5 BILLION common shares outstanding now. The HEMP dilution machine has literally, an endless supply of new HEMP common shares for sale.
Liquidity is slowly drying up in APRU. Average daily trading volumes are in a steep decline.
ACB’s market cap is sooo stretched. Price to sales multiple is just plain goofy high. When a stock is priced for perfection in the stratosphere, it better not miss already lowered rev expectations.
On August 29th LRSV shares were trading at .021/share.
Today LRSV shares finished at .008565/share.
So in just 8 trading sessions LRSV shares have lost more than 59% in value.
HEMP’s Quarterly Report linked below is terribly flawed. The Statement of Operations on Page 13 does not match up with its Statement of Cash Flows in Page 18. Columns on page 13 messed up too. Who prepared this Quarterly Report? Page 13 states Net Loss of ($8,582,326) for first 6 months of 2019. But, Page 18 states Net Loss of ($13,730,157) for the first 6 months of 2019. HEMPS books aren’t adding up.
https://www.hempinc.com/wp-content/uploads/2019/09/HEMP-2019-2nd-QTR-Filing.pdf
Less than $2,000 in trades today. Don’t know how DIRV can raise necessary capital when DIRV has nearly $25,000,000 in debts. No way to pay back the $25,000,000 in debts if less than $2000 in DIRV stock trades. Liquidity is drying up. People should understand the math. It’s busted.
I have a background in banking so I am aware of how long audits take to complete.
HEMP is losing a lot more money.
For the first 6 months of 2018 HEMP posted a Net Loss of ($5,177,218)
For the first 6 months of 2019 HEMP posted a Net Loss of ($8,582,326)
And it’s not just that net losses are growing fast but the losses are accelerating if you examine Quarter over Quarter over Quarter.
Not that I’m a believer in technical analysis on stinky pinkies but just noticed Barchart.com has a strong sell rating on HEMP too.
Think about this....HEMP has a total market value of about $10 million dollars, but the company lost more than $8.5 million dollars in the last 6 months alone.
https://www.barchart.com/stocks/quotes/HEMP/overview
Remember this HIPH PR from June? Ryan Fishoff stated that 30,000,000 shares would be returned to treasury and you know what? Total BS because those 30,000,000 shares were never retired. In fact just the opposite. HIPH has issued tens of millions new common shares since June.
https://www.globenewswire.com/news-release/2019/06/03/1863142/0/en/American-Premium-Water-Corp-OTC-HIPH-Announces-That-It-Is-Returning-30-Million-Common-Shares-to-Treasury-Reducing-Outstanding-Common-Shares.html
In all seriousness, given all the false and misleading PR’s from Ryan, all the retracted and restated 10-Q’s, price per share performance, Ryan Fishoff should resign or be replaced. Nothing the company has stated in PR’s has proved to be truthful.
Interesting....zero volume. What’s the matter? Nobody thinks a company with $0 in assets is worth a $1.3 million dollar valuation?
Liquidity is drying up in DIRV.